Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...

Aarhus, Denmark, 12 February 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announced that top-line data ...

Q4 2025 Earnings Call February 24, 2026 7:01 PM ESTCompany ParticipantsRyan Kolln - CEO, MD & DirectorJustin Miles - ...

Press Release Paris, 3rd March, 2026 Progress against FOCUS-27 in a deteriorating environment Accelerated transformation to strengthen the operating model Full-year 2025 results €848.2 million net ...

Learn how the framing effect influences decision-making in investments, and discover strategies to identify and mitigate its ...

And that was also presented at ASH 2025 and also a very, very strong data set. I should mention that BI-1808 that was monotherapy, single-agent therapy. Then, we also started our Phase IIa trial ...

Data debt doesn’t usually announce itself with obvious symptoms like dramatic system failures and missed deadlines. Instead, it accumulates quietly in the form of outdated processes, inconsistent ...

Air France-KLM (EURONEXT:AF) reported record financial results for fiscal year 2025, with operating profit breaking the €2 billion mark and operating margin improving to 6.1%, according to the company ...

An Eastside High School student is headed to the prestigious Regeneron International Science and Engineering Fair after winning the top prize in the Alachua Regional fair. Sophomore Pranav Mannam took ...

DSM-Firmenich AG (XAMS:0AC9) shares plummeted 43.52% following its FY 2025 results presentation on February 12, 2026, despite reporting modest organic growth and completing a strategic transformation.

SSC Phase-13 2025 Result: The Staff Selection Commission (SSC) has declared the results of the Phase-13 Selection Post 2025 CBT examination. The commission has declared the results for Matriculation, ...